Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

853.31 (Glytoucan)

Id:f62005ad-8122-5ff7-b4f1-c18c440e6fad

Glytoucan:G60033IX

Results found

Linked to

	Label	Description
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G88572NY-GLYCOSEQ00142916 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G96044KA-GLYCOSEQ00080689 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G44111WR-GLYCOSEQ00022553 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G82935CH-GLYCOSEQ00039037 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G71688NS-GLYCOSEQ00013418 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G83916HL-GLYCOSEQ00098916 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has motif a-Gal antigen Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G13630UH-GLYCOSEQ00137157 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G25873ET-GLYCOSEQ00025869 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G42803PB-GLYCOSEQ00156242 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G88572NY-GLYCOSEQ00142916 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G96044KA-GLYCOSEQ00080689 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G44111WR-GLYCOSEQ00022553 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G82935CH-GLYCOSEQ00039037 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G71688NS-GLYCOSEQ00013418 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G83916HL-GLYCOSEQ00098916 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has motif a-Gal antigen

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G13630UH-GLYCOSEQ00137157 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G25873ET-GLYCOSEQ00025869 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

853.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G42803PB-GLYCOSEQ00156242 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.